Status:
NOT_YET_RECRUITING
Phenytoin in Treatment of Atrophic Post Acne Scars.
Lead Sponsor:
Assiut University
Conditions:
Atrophic Acne Scar
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To evaluate the efficacy and safety of topical phenytoin spanlastics as an adjuvant therapy in treatment of atrophic post acne scars. To compare the efficacy of topical phenytoin spanlastics combined...
Detailed Description
Acne is one of the most dermatological problems in the world which causes scars as secondary damage . It affects the appearance and psychology of the patient badly . There are three main types of sca...
Eligibility Criteria
Inclusion
- Patients aged equal or more than 18 years old with atrophic post acne scars.
Exclusion
- Pregnancy and lactation
- Hypertrophic scars
- Kidney, liver, neurological, haematological, malignant or immunosuppressive diseases.
- Active infection at the site of the scars
- Patients use medications that reduced tissue healing during the study or in a period less than one month ago (immunosuppressants and isotretinoin).
- Patients who are taking anticoagulants or NSAIDS within the past 48h.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06942468
Start Date
July 1 2025
End Date
August 1 2027
Last Update
April 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.